RNA干扰技术在肿瘤研究中的应用
Application of RNA interference in tumour research
摘要
RNA干扰 (RNAi)是近几年发展起来的一种阻抑基因表达的新方法 ,它通过双链RNA的介导 ,特异性地阻断或降低相应基因的表达。目前 ,随着RNAi分子机制研究的不断深入 ,作为研究功能基因组有力工具的RNAi技术 ,有可能选择性地抑制人类疾病相关基因的表达 ,从而为肿瘤等人类疾病基因治疗带来新的希望。
出处
《国外医学（肿瘤学分册）》
2004年第12期883-885,共3页
Foreign Medical Sciences (Cancer Section)
参考文献21
-
1Fire A,Xu S, Montgomery MK,et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature,1998,391 ( 6669 ): 806-811.
-
2Zamore PD, Tuschl T, Sharp PA, et al. RNAi:double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals. Cell,2000,101 ( 1 ) :25-33.
-
3Hutvagner G,Zamore PD. RNAi:nature abhors a double-strand. Curr Opin Genet Dev,2002,12(2) :225-232.
-
4Elbashir SM, Lendeckel W, Tuschl T. RNA interference is mediated by 21 -and 22 -nucleotide RNAs. Genes Dev,2001,15 (2): 188-200.
-
5Sijen T,Fleenor J,Simmer F,et al. On the role of RNA amplification in dsRNA-triggered gene silencing. Cell ,2001,107 (4) :465-476.
-
6Lipardi C,Wei Q,Paterson BM. RNAi as random degradative PCR:siRNA primers convert mRNA into dsRNAs that are degraded to generate new siRNAs. Cell ,2001,107 ( 3 ) :297-307.
-
7Elbashir SM, Harborth J, Lendeckel W, et al. Duplexes of 21 -nucleotide RNAs mediate RNA interference in cultured mammalian cells.Nature ,2001,411 (6836) :494-498.
-
8Varambally S, Dhanasekaran SM, Zhou M, et al. The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature,2002,419 (6907) :624-629.
-
9DiTullio RA Jr, Mochan TA, Venere M, et al. 53BP1 functions in an ATM-dependent checkpoint pathway that is constitutively activated in human cancer. Nat Cell Biol,2002,4(12) :998-1002.
-
10Hemann MT, Fridman JS, Zilfou JT, et al. An epi-allelic series of p53 hypomorphs created by stable RNAi produces distinct tumor phenotypes in vivo. Nat Genet,2003,33(3) :396-400.
-
1杜军,周晓军.荧光原位杂交技术在实体瘤诊断中的应用[J].医学研究生学报,2009,22(2):213-216. 被引量：8
-
2郑天荣,力超,郑秋红,谢云青,龚福生,汪相如.甲状腺癌组织差异表达cDNA消减文库的构建与鉴定[J].肿瘤防治杂志,2003,10(9):913-916.
-
3苏红英,张鹏飞,郑秋红,郑天荣,黄雄飞.人胃印戒细胞癌组织cDNA消减文库的构建[J].福建医科大学学报,2004,38(2):141-145.
-
4王智睿,陈晓光.双特异性单克隆抗体在肿瘤治疗中的应用[J].国外医学（肿瘤学分册）,2005,32(4):270-273.
-
5查智健(综述),于德新(审校).肾细胞癌染色体异常的研究进展[J].国际泌尿系统杂志,2009,29(3):323-326. 被引量：1
-
6刘俊茹,郑朝旭,罗绍凯,李娟,苏畅.可溶性FLT-1基因的克隆以及原核表达[J].中华肿瘤防治杂志,2006,13(15):1143-1146.
-
7齐妍,常彬,李锋.软组织肉瘤染色体畸变的检测技术及进展[J].医学分子生物学杂志,2006,3(1):80-82. 被引量：1
-
8吴伟华,顾国浩,滕小梅.DIAPH3,一个新的肝细胞癌相关基因的筛选及功能研究[J].江苏医药,2012,38(24):2955-2958. 被引量：1
-
9胡建达,陈晓梨,陈鑫基,祝亮方,杨月玲,陈元仲,吕联煌.抑制性消减杂交法研究初治和复发急性淋巴细胞白血病基因的差异表达[J].福建医科大学学报,2003,37(3):250-252. 被引量：1
-
10周珏宇,马文丽,丁大鹏,石嵘,郑文岭.慢性髓细胞性白血病患者与健康人骨髓单个核细胞基因表达的差异(英文)[J].中国临床康复,2006,10(9):179-182.
